Andere Kunden interessierten sich auch für
![Characterization and Resistotyping of Pathogenic Staphylococci]( "Characterization and Resistotyping of Pathogenic Staphylococci")
Characterization and Resistotyping of Pathogenic Staphylococci51,99 €![Mechanisms of Acquired Chemotherapeutic Resistance in Gliomas]( "Mechanisms of Acquired Chemotherapeutic Resistance in Gliomas")
Mechanisms of Acquired Chemotherapeutic Resistance in Gliomas44,99 €![Molecular mechanisms induced by p53 reactivating molecules]( "Molecular mechanisms induced by p53 reactivating molecules")
Molecular mechanisms induced by p53 reactivating molecules30,99 €![Molecular Mechanisms of Non-Small Cell Lung Cancer]( "Molecular Mechanisms of Non-Small Cell Lung Cancer")
Molecular Mechanisms of Non-Small Cell Lung Cancer39,99 €![Identification of Pathogenic Fungi]( "Identification of Pathogenic Fungi")
Identification of Pathogenic Fungi192,99 €![Understanding Type I Diabetes and the Underlying Physiological Mechanisms]( "Understanding Type I Diabetes and the Underlying Physiological Mechanisms")
Understanding Type I Diabetes and the Underlying Physiological Mechanisms9,99 €![Mechanisms underlying cannabis effects on the brain]( "Mechanisms underlying cannabis effects on the brain")
Mechanisms underlying cannabis effects on the brain36,99 €
Huntington disease (HD) is a progressive neurodegenerative disease for which there is no cure or effective treatment. Despite a relatively long history of research in HD, the pathogenic mechanisms of HD remain to be fully elucidated, thereby hampering the development of therapeutic approaches. This study demonstrates that transcriptional dysregulation of PPARgamma, PGC-1alpha, and CRE, altered metabolism, and oxidative stress are involved in the pathogenesis of HD. In addition, this study shows that metabolic state affects sensitivity to cellular stress in a cell model of HD and the activation of PPARgamma, an important regulator in metabolism, leads to beneficial effects in HD models. This study will provide better understanding of how mHtt results in metabolic disturbances in HD and more insight for the development of therapeutics to treat HD with PPARgamma being a potential therapeutic target for HD. This book should be especially useful to professionals in biological sciences, healthcare/medical fields, and pharmaceutical industry, or anyone else who is interested in understanding HD or neurodegenerative diseases.